TN2012000342A1 - Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies

Info

Publication number
TN2012000342A1
TN2012000342A1 TNP2012000342A TN2012000342A TN2012000342A1 TN 2012000342 A1 TN2012000342 A1 TN 2012000342A1 TN P2012000342 A TNP2012000342 A TN P2012000342A TN 2012000342 A TN2012000342 A TN 2012000342A TN 2012000342 A1 TN2012000342 A1 TN 2012000342A1
Authority
TN
Tunisia
Prior art keywords
receptor
interleukin
antibodies
formulations containing
containing anti
Prior art date
Application number
TNP2012000342A
Inventor
Daniel B Dix
Kenneth S Graham
Douglas E Kamen
Scott M Walsh
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/020457 external-priority patent/WO2011085158A2/en
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of TN2012000342A1 publication Critical patent/TN2012000342A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-6 receptor (hlL-6R). The formulations may contain, in addition to an anti-hlL-6R antibody, at least one amino acid, at least one sugar, and/or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.
TNP2012000342A 2010-01-08 2012-06-29 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies TN2012000342A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29327710P 2010-01-08 2010-01-08
PCT/US2011/020457 WO2011085158A2 (en) 2010-01-08 2011-01-07 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies

Publications (1)

Publication Number Publication Date
TN2012000342A1 true TN2012000342A1 (en) 2013-12-12

Family

ID=61002420

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2012000342A TN2012000342A1 (en) 2010-01-08 2012-06-29 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies

Country Status (1)

Country Link
TN (1) TN2012000342A1 (en)

Similar Documents

Publication Publication Date Title
JO3417B1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
MX2019008084A (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies.
JO3449B1 (en) Stabilized formulations containing anti-ngf antibodies
PH12019502123A1 (en) Stable antibody formulation
PH12014501628B1 (en) Stabilized formulations containing anti-ang2 antibodies
MY157772A (en) Antibody formulation
TN2009000382A1 (en) Stable antibody formulations
PH12014502778A1 (en) Antibody formulation
MX2020010470A (en) Stabilized formulations containing anti-pcsk9 antibodies.
MX2021011137A (en) Stabilized formulations containing anti-il-33 antibodies.
UY33652A (en) STABILIZED FORMULATIONS CONTAINING ANTI-RECEIVER ANTIBODIES OF INTERLEUCINE-4 (IL-AR)
TN2012000342A1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies